SCHEMBL11896250

SCHEMBL11896250

C1=Cc2cc3ccc(cc4nc(cc5ccc(cc1n2)[nH]5)c1c2cccc5cccc(c4=1)c52)[nH]3

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ STAT3 P40763 1/20 0.32
▸ STAT1 P42224 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3116089 0.87 CYP1A2 (0.39) STAT3STAT1
SCHEMBL27629845 0.85 CYP1A2 (0.38) STAT3STAT1
Pyrene SCHEMBL223706 0.80 ALDH1A1 (0.44) STAT3STAT1
Pyrene SCHEMBL27924575 0.79 CYP1A2 (0.42) STAT3STAT1
SCHEMBL9298253 0.78 GSK3B (0.42) STAT3STAT1
Triphenylene SCHEMBL28084435 0.76 STAT3 (0.44) STAT3STAT1
Ammonia Solution, Strong SCHEMBL9294672 0.76 STAT3 (0.41) STAT3STAT1
Ammonia Solution, Strong SCHEMBL6411756 0.76 STAT3 (0.41) STAT3STAT1
SCHEMBL9718813 0.76 STAT3 (0.41) STAT3STAT1
Ammonia Solution, Strong SCHEMBL6769552 0.76 STAT3 (0.41) STAT3STAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9327017-B2 Leishmania-based carrier for vaccine delivery ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE (US) 2016-05-03 — — US disclosed
US-8431117-B2 Sickled erythrocytes with anti-tumor agents induce tumor vaso-occlusion and tumoricidal effects TERMAN DAVID S (US) 2013-04-30 — — US disclosed
US-20120288524-A1 LEISHMANIA-BASED CARRIER FOR VACCINE DELIVERY ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE (US) 2012-11-15 — — US disclosed
US-20120195869-A1 Sickled Erythrocytes with Anti-tumor Agents Induce Tumor Vaso-occlusion and Tumoricidal Effects TERMAN DAVID S (US) 2012-08-02 — — US disclosed
Send feedback